Nexgel Inc (NXGL) - Net Assets
Based on the latest financial reports, Nexgel Inc (NXGL) has net assets worth $4.48 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.60 Million) and total liabilities ($7.12 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nexgel Inc (NXGL) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.48 Million |
| % of Total Assets | 38.64% |
| Annual Growth Rate | 22.39% |
| 5-Year Change | -59.53% |
| 10-Year Change | N/A |
| Growth Volatility | 5325.5 |
Nexgel Inc - Net Assets Trend (2016–2025)
This chart illustrates how Nexgel Inc's net assets have evolved over time, based on quarterly financial data. See NXGL defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Nexgel Inc (2016–2025)
The table below shows the annual net assets of Nexgel Inc from 2016 to 2025. For live valuation and market cap data, see NXGL market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $4.89 Million | -19.56% |
| 2024-12-31 | $6.08 Million | +17.69% |
| 2023-12-31 | $5.17 Million | -32.36% |
| 2022-12-31 | $7.64 Million | -36.81% |
| 2021-12-31 | $12.09 Million | +16921.13% |
| 2020-12-31 | $71.00K | -81.32% |
| 2019-12-31 | $380.00K | +35.23% |
| 2018-12-31 | $281.00K | -55.04% |
| 2017-12-31 | $625.00K | -21.28% |
| 2016-12-31 | $794.00K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Nexgel Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2099600000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $8.00K | 0.18% |
| Other Components | $25.45 Million | 570.69% |
| Total Equity | $4.46 Million | 100.00% |
Nexgel Inc Competitors by Market Cap
The table below lists competitors of Nexgel Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CDT Environmental Technology Investment Holdings Limited ordinary shares
NASDAQ:CDTG
|
$5.17 Million |
|
CPI Computer Peripherals International
AT:CPI
|
$5.17 Million |
|
Rokeby Resources Limited
AU:RKB
|
$5.17 Million |
|
Cape Range Ltd
AU:CAG
|
$5.17 Million |
|
Kontigo Care AB
ST:KONT
|
$5.16 Million |
|
YGL Convergence Bhd
KLSE:0086
|
$5.15 Million |
|
GRAND PEAK CAPITAL
F:6GP1
|
$5.15 Million |
|
Tatton Asset Management plc
LSE:TAM
|
$5.15 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nexgel Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,755,000 to 4,459,000, a change of -1,296,000 (-22.5%).
- Net loss of 3,000,000 reduced equity.
- New share issuances of 963,000 increased equity.
- Other factors increased equity by 741,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.00 Million | -67.28% |
| Share Issuances | $963.00K | +21.6% |
| Other Changes | $741.00K | +16.62% |
| Total Change | $- | -22.52% |
Book Value vs Market Value Analysis
This analysis compares Nexgel Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.08x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.28x to 1.08x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.14 | $0.61 | x |
| 2017-12-31 | $0.11 | $0.61 | x |
| 2018-12-31 | $0.05 | $0.61 | x |
| 2019-12-31 | $0.07 | $0.61 | x |
| 2020-12-31 | $0.01 | $0.61 | x |
| 2021-12-31 | $2.17 | $0.61 | x |
| 2022-12-31 | $1.37 | $0.61 | x |
| 2023-12-31 | $0.83 | $0.61 | x |
| 2024-12-31 | $0.88 | $0.61 | x |
| 2025-12-31 | $0.57 | $0.61 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nexgel Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -67.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -26.27%
- • Asset Turnover: 1.09x
- • Equity Multiplier: 2.35x
- Recent ROE (-67.28%) is above the historical average (-503.21%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | -223.68% | -82.53% | 1.71x | 1.59x | $-1.86 Million |
| 2017 | -152.48% | -47.84% | 2.23x | 1.43x | $-1.02 Million |
| 2018 | -671.89% | -85.31% | 2.99x | 2.63x | $-1.92 Million |
| 2019 | -506.05% | -268.20% | 0.38x | 4.97x | $-1.96 Million |
| 2020 | -3188.73% | -335.91% | 0.30x | 31.79x | $-2.27 Million |
| 2021 | -35.66% | -277.89% | 0.09x | 1.41x | $-5.52 Million |
| 2022 | -62.14% | -231.74% | 0.20x | 1.36x | $-5.51 Million |
| 2023 | -67.21% | -77.21% | 0.41x | 2.12x | $-3.63 Million |
| 2024 | -57.01% | -37.76% | 0.79x | 1.91x | $-3.86 Million |
| 2025 | -67.28% | -26.27% | 1.09x | 2.35x | $-3.45 Million |
Industry Comparison
This section compares Nexgel Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,252,702,307
- Average return on equity (ROE) among peers: -94.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nexgel Inc (NXGL) | $4.48 Million | -223.68% | 1.59x | $5.16 Million |
| Akoya Biosciences Inc (AKYA) | $7.59 Million | -728.97% | 15.46x | $64.44 Million |
| Align Technology Inc (ALGN) | $-84.67 Million | 0.00% | 0.00x | $12.09 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $447.90 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $483.76 Million | 10.38% | 0.27x | $1.37 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $18.90 Million | -243.53% | 0.62x | $924.75 Million |
| Avantor Inc (AVTR) | $4.86 Billion | 14.14% | 1.77x | $5.44 Billion |
| Azenta Inc (AZTA) | $121.80 Million | -15.11% | 0.16x | $1.05 Billion |
| Baxter International Inc (BAX) | $4.09 Billion | 0.98% | 1.08x | $9.94 Billion |
About Nexgel Inc
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It a… Read more